Plasma exosomal miR-137 activates natural killer cells in primary biliary cholangitis by targeting NFATC1

Figure 5 Fluorescence intensity. A: Demonstrated reduced absorbance of microRNA-137 (miR-137) negative control (NC) wild-type (WT) compared to miR-137 WT (P < 0.05), while no significant difference in absorbance between miR-137 NC 3’ UTR mutant (MUT) and miR-137 MUT, indicating that miR-137 reduces luciferase activity by binding nuclear factor of activated T cell 1; B: Showed no significant change in absorbance between miR-124 NC WT compared to miR-124 WT, miR-124 NC MUT, and miR-124 MUT; C: Demonstrated no significant change in absorbance between miR-506 NC WT and miR-506 WT, miR-506 NC MUT, and miR-506 MUT.